首页> 美国政府科技报告 >Determination of In-Vitro Lung Solubility and Intake-to-Dose Conversion Factor for Tritiated Lanthanum Nickel Aluminum Alloy.
【24h】

Determination of In-Vitro Lung Solubility and Intake-to-Dose Conversion Factor for Tritiated Lanthanum Nickel Aluminum Alloy.

机译:氚化镧镍铝合金体外肺溶解度和摄入剂量转换因子的测定。

获取原文

摘要

A sample of tritiated lanthanum nickel aluminum alloy (LaNi4.25Al0.75 or LANA.75) similar to that used at the Savannah River Site Tritium Facilities was analyzed to estimate the particle size distribution of this metal tritide powder and the rate, at which this material dissolves in the human respiratory tract after it is inhaled. This information is used to calculate the committed effective dose received by a worker after inhaling the material. These doses, which were calculated using the same methodology given in the DOE Tritium Handbook, are presented as inhalation intake-to-dose conversion factors (DCF). The DCF for this metal tritide is less than the DCF for tritiated water and radiation worker bioassay programs designed for tritiated water are adequate to monitor for intakes of this material.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号